טוען...
Utilizing cell-based therapeutics to overcome immune evasion in hematologic malignancies
Hematologic malignancies provide a suitable testing environment for cell-based immunotherapies, which were pioneered by the development of allogeneic hematopoietic stem cell transplant. All types of cell-based therapies, from donor lymphocyte infusion to dendritic cell vaccines, and adoptive transfe...
שמור ב:
| הוצא לאור ב: | Blood |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Hematology
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4929926/ https://ncbi.nlm.nih.gov/pubmed/27207792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-12-629089 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|